Higher Bcl-2 levels decrease staphylococcal superantigen-induced apoptosis of CD4+ T cells in atopic dermatitis

Area of Science:

• Immunology
• Dermatology
• Cell Biology

Background:

• Staphylococcal superantigens (SsAgs) are implicated in persistent allergic skin inflammation in atopic dermatitis (AD).
• Understanding the role of SsAgs and their interaction with T cells is crucial for AD pathogenesis.
• Investigating cellular mechanisms of T cell survival in AD is essential for developing targeted therapies.

Purpose of the Study:

• To compare SsAg-induced caspase-3 activation and Bcl-2 expression in CD4+ T cells between AD patients and healthy individuals.
• To determine the effect of interleukin-4 (IL-4) on SsAg-induced apoptosis in CD4+ T cells.
• To elucidate the role of IL-4 in regulating T cell responses to SsAgs in AD.

Main Methods:

• Analysis of peripheral blood mononuclear cells from 16 AD patients and 14 healthy subjects.
• Stimulation with staphylococcal enterotoxin B (SEB) in the presence or absence of IL-4 or anti-IL-4 antibodies.
• Assessment of caspase-3 activation, Bcl-2 protein, and Bcl-2 mRNA levels using flow cytometry and real-time PCR.

Main Results:

• AD patient CD4+ T cells showed reduced caspase-3 activation and Bcl-2/mRNA decrease upon SEB stimulation compared to healthy subjects.
• Exogenous IL-4 inhibited SEB-induced caspase-3 activation and Bcl-2 reduction in healthy T cells.
• Anti-IL-4 antibodies enhanced SEB-induced caspase-3 activation and Bcl-2 reduction in AD T cells.

Conclusions:

• IL-4 produced by T cells in AD down-regulates SsAg-induced CD4+ T cell apoptosis by preserving Bcl-2 levels.
• This IL-4-mediated effect may hinder the clearance of SsAg-activated T cells.
• Impaired T cell apoptosis may contribute to the persistence of allergic skin inflammation in atopic dermatitis.